Effectiveness of tocilizumab in patients hospitalized with COVID-19

What The Study Did:


This follow-up study of a randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.

Authors:


Xavier Mariette, M.D., Ph.D., of the


Hôpital Bicêtre in


Bicêtre, France

, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamainternmed.2021.2209)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamainternalmedicine/

fullarticle/

10.

1001/

jamainternmed.

2021.

2209?guestAccessKey=

3e763124-a278-45ae-bc47-a1d2baea4f72&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

052421